The beginning of the rpoB gene in addition to the rifampin resistance determination region might be needed for identifying rifampin/rifabutin cross-resistance in multidrug-resistant Mycobacterium tuberculosis isolates from Southern China

Journal of Clinical Microbiology

Volumn 50, Issue 1, 2012, Pages 81-85

  Tan, Yaoju ^a   Hu, Zuqiong ^a   Zhao, Yanlin ^b   Cai, Xingshan ^a   Luo, Chunming ^a   Zou, Cairong ^a   Liu, Xin ^a  

^a GUANGZHOU CHEST HOSPITAL   (China)

^b DEPARTMENT OF HEALTH   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL DNA; ETHAMBUTOL; ISONIAZID; RIFABUTIN; RIFAMPICIN; STREPTOMYCIN;

ACCURACY; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CHINA; CODON; CONTROLLED STUDY; CROSS RESISTANCE; DNA SEQUENCE; GENE MUTATION; MULTIDRUG RESISTANCE; MUTATION RATE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; RPOB GENE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTITUBERCULAR AGENTS; BACTERIAL PROTEINS; CHINA; DNA, BACTERIAL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; HUMANS; MIDDLE AGED; MUTATION, MISSENSE; MYCOBACTERIUM TUBERCULOSIS; RIFABUTIN; RIFAMPIN; SEQUENCE ANALYSIS, DNA; TUBERCULOSIS, MULTIDRUG-RESISTANT; YOUNG ADULT;

MYCOBACTERIUM TUBERCULOSIS;

EID: 84555178959     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.05092-11     Document Type: Article

References (20)

1. Boehme CC, et al. 2010. Rapid molecular detection of tuberculosis and rifampin resistance. N. Engl. J. Med. 363:1005-1015.
2. Cavusoglu C, Karaca-Derici Y, Bilgic A. 2004. In-vitro activity of rifabutin against rifampicin-resistant Mycobacterium tuberculosis isolates with known rpoB mutations. Clin. Microbiol. Infect. 10:662-665. (Pubitemid 39077057)
3. Cavusoglu C, Turhan A, Akinci P, Soyler I. 2006. Evaluation of the genotype MTBDR assay for rapid detection of rifampin and isoniazid resistance in Mycobacterium tuberculosis isolates. J. Clin. Microbiol. 44: 2338-2342. (Pubitemid 44092395)
4. Chikamatsu K, Mizuno K, Yamada H, Mitarai S. 2009. Cross-resistance between rifampicin and rifabutin among multi-drug resistant Mycobacterium tuberculosis strains. Kekkaku 84:631-633. (In Japanese.)
5. Cirillo DM, et al. 2004. Direct rapid diagnosis of rifampicin resistant Mycobacterium tuberculosis infection in clinical samples by line probe assay (INNO LiPA Rif. TB).New Microbiol. 27:221-227. (Pubitemid 40089472)
6. Heep M, Rieger U, Beck D, Lehn N. 2000. Mutations in the beginning of the rpoB gene can induce resistance to rifamycins in both Helicobacter pylori and Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 44:1075-1077. (Pubitemid 30165295)
7. Heep M, et al. 2001. Frequency of rpoB mutations inside and outside the cluster I region in rifampin-resistant clinical Mycobacterium tuberculosis isolates. J. Clin. Microbiol. 39:107-110. (Pubitemid 32059577)
8. Helb D, et al. 2010. Rapid detection of Mycobacterium tuberculosis and rifampin resistance by use of on-demand, near-patient technology. J. Clin. Microbiol. 48:229-237.
9. Kunin CM. 1996. Antimicrobial activity of rifabutin. Clin. Infect. Dis. 22:S3-S13.
10. Lee ASG, Lim IHK, Tang LLH, Wong SY. 2005. High frequency of mutations in the rpoB gene in rifampin-resistant clinical isolates of Mycobacterium tuberculosis from Singapore. J. Clin. Microbiol. 43: 2026-2027.
11. Matsiota-Bernard P, Vrioni G, Marinis E. 1998. Characterization of rpoB mutations in rifampin-resistant clinical Mycobacterium tuberculosis isolates from Greece. J. Clin. Microbiol. 36:20-23. (Pubitemid 28047426)
12. Ohno H, Koga H, Kohno S, Tashiro T, Hara K. 1996. Relationship between rifampin MICs for and rpoB mutations of Mycobacterium tuberculosis strains isolated in Japan. Antimicrob. Agents Chemother. 40: 1053-1056. (Pubitemid 26115251)
13. Ozkutuk N, Gazi H, Surucuoglu S, Ganduz A, Ozbakkaloglu B. 2007. Characterization of rpoB mutations by line probe assay in rifampicin-resistant Mycobacterium tuberculosis clinical isolates from the Aegean region in Turkey. Jpn. J. Infect. Dis. 60:211-213. (Pubitemid 47365044)
14. Ramaswamy S, Musser JM. 1998. Molecular genetic basis of antimicrobial agent resistance in Mycobacterium tuberculosis. Tuber. Lung Dis. 79:3-29. (Pubitemid 29050434)
15. Sintchenko V, Chew WK, Jelfs PJ, Gilbert GL. 1999. Mutations in rpoB gene and rifabutin susceptibility of multidrug-resistant Mycobacterium tuberculosis strains isolated in Australia. Pathology 31: 257-260. (Pubitemid 29417609)
16. Siu GKH, et al. 2011. Mutations outside the rifampicin resistance-determining region associated with rifampicin resistance in Mycobacterium tuberculosis. J. Antimicrob. Chemother. 66:730-733.
17. Telenti A, et al. 1993. Detection of rifampin-resistance mutations in Mycobacterium tuberculosis. Lancet 341:647-650. (Pubitemid 23083244)
18. Williams DL, et al. 1998. Contribution of rpoB mutations to development of rifamycin cross-resistance in Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 42:1853-1857. (Pubitemid 28311593)
19. World Health Organization. 2010. Multidrug and extensively drug-resistant TB (M/XDR-TB). 2010 global report on surveillance and response. World Health Organization, Geneva, Switzerland.
20. World Health Organization. 2008. Guidelines for the programmatic management of drug-resistant tuberculosis. Emergency update 2008. World Health Organization, Geneva, Switzerland.